Kymera Therapeutics Stock Target Price and Analyst Consensus
| KYMR Stock | USD 44.98 1.47 3.38% |
The current analyst and expert consensus on Kymera Therapeutics is Strong Buy with 4 hold recommendations. The current projected Kymera Therapeutics target price consensus is 56.53 with 17 analyst opinions. One of the most common ways Kymera Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Kymera Therapeutics vendors, executives, and/or customers. Kymera Therapeutics recommendation module provides expert sentiment on the projected Kymera Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 3.057.
Lowest Forecast 51.44 | Highest Forecast 62.75 | Target Price 56.53 |
Kymera |
It's important to approach Kymera Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Kymera Therapeutics price targets
Kymera Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Kymera Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Kymera Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Kymera Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Kymera Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Kymera Therapeutics is a key component of Kymera Therapeutics valuation and have some predictive power on the future returns of a Kymera Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Momentum Invested over 40 shares | |
 | Artificial Intelligence Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Manufacturing Invested over 30 shares | |
 | FinTech Invested over 60 shares | |
 | Hedge Favorites Invested few shares |
Additional Tools for Kymera Stock Analysis
When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.